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Cofilin-actin rod formation in 
experimental stroke is attenuated 
by therapeutic hypothermia and 
overexpression of the inducible 70 kD 
inducible heat shock protein (Hsp70)
Kota Kurisu1, Jesung You1,2, Zhen Zheng1, Seok Joon Won1, Raymond A Swanson1, 
Midori A Yenari1
Abstract:
BACKGROUND AND PURPOSE: Cofilin‑actin rods are covalently linked aggregates of cofilin‑1 and 
actin. Under ischemic conditions, these rods have been observed in neuronal dendrites and axons and 
may contribute to the loss of these processes. Hypothermia (Hypo) and the 70 kD inducible heat shock 
protein (Hsp70) are both known to improve outcomes after stroke, but the mechanisms are uncertain. 
Here, we evaluated the effect of these factors on cofilin‑actin rod formation in a mouse model of stroke.
MATERIALS AND METHODS: Mice were subjected to distal middle cerebral artery occlusion (dMCAO) 
and treated with Hypo using a paradigm previously shown to be neuroprotective. We similarly studied 
mice that overexpressed transgenic (Tg) or were deficient knockout (Ko) in the inducible 70 kDa heat 
shock protein (Hsp70), also previously shown to be protective by our group and others. Cofilin‑actin 
rod formation was assessed by histological analysis at 4 and 24 h after dMCAO. Its expression was 
analyzed in three different regions, namely, infarct core (the center of the infarct), middle cerebral 
artery (MCA) borderzone (the edge of the brain regions supplied by the MCA), and the ischemic 
borderzone (border of ischemic lesion). Ischemic lesion size and neurological deficits were also 
assessed.
RESULTS: Both Hypo‑treated and Hsp70 Tg mice had smaller lesion sizes and improved neurological 
outcomes, whereas Hsp70 Ko mice had larger lesion sizes and worsened neurological outcomes. 
Cofilin‑actin rods were increased after stroke, but were reduced by therapeutic Hypo and in Hsp70 
Tg mice. In contrast, cofilin‑actin rods were increased in ischemic brains of Hsp70 Ko mice.
CONCLUSIONS: Cofilin‑actin rod formation was suppressed under the conditions of neuroprotection 
and increased under circumstances where outcome was worsened. This suggests that cofilin‑actin 
rods may act to participate in or exacerbate ischemic pathology and warrants further study as a 
potential therapeutic target.
Keywords:
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Introduction
Cofilin‑actin rods, or cofilin rods, are linear intracellular aggregates 
comprised of a 1:1 ratio of actin and cofilin 
that form selectively in neurons, and 
have been observed largely in neurites. 
These rods have been characterized in 
human Alzheimer’s disease and in models 
of neurodegenerative disorders, where 
they have been suggested to contribute 
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to neurodegeneration.[1] Cofilin rods are induced by 
adenosine triphosphate (ATP) depletion or oxidative 
stress, both of which have been well documented in 
brain ischemia. The biochemical factors driving rod 
formation are now well established. One key step is 
dephosphorylation of cofilin‑1, through reduced activity 
of LIM kinase or increased activity of slingshot (SL) 
phosphatase SL‑1, which promotes cofilin‑1 binding to 
actin. A second key step is the formation of intermolecular 
disulfide bonds between cofilin‑1 molecules.[1,2] The rods 
form macromolecular aggregates that interrupt the 
microtubule skeleton within affected neurites and, as 
such, may affect organelle transport and lead to synapse 
disruption and loss of dendritic spines. A causal link 
between rod formation and distal neurite demise has 
been demonstrated by simple overexpression of cofilin‑1, 
which is sufficient to induce rod formation and associated 
neurite degeneration.[3] It has also been demonstrated by 
neurite preservation after targeted suppression of rod 
formation.[4,5] The mechanisms by which rod formation 
causes neurite demise remain to be established, but 
impaired axonal and dendritic transport, mitochondrial 
fission, prolonged mitochondrial depolarization, and 
ATP depletion have been observed in neurite‑containing 
rods, and may be contributory.[3,6‑8] In neuron cultures, 
rods can be induced by peroxide, ATP depletion, 
glutamate, and endothelin 1.[3,5,6]
Studies on Alzheimer’s disease indicate that rod 
formation may be triggered by Aβ protein and prion 
protein‑dependent generation of reactive oxygen 
species. Further, loss of dendrites and spines has been 
correlated to cognitive impairment.[9] Dendritic injury 
has been less studied in brain ischemia, but it has been 
established that ischemia also leads to loss of dendrites 
and spines in neurons, even with survival of the parent 
cell body.[10‑14] A recent article from our group showed 
cofilin rod formation after both transient and permanent 
brain ischemia.[15] Rod formation was observed within 
4 h after reperfusion, and where infarction occurred, 
rods persisted for at least 24 h and extended into the 
peri‑infarct tissue. Rods were observed only in neurons, 
and within cell bodies as well as processes, particularly 
dendrites. In another recent study, suppression of rod 
formation using viral‑mediated overexpression of LIM 
kinase showed a protective effect on synaptic function 
and dendritic structure in both cultured neurons and a 
rat transient ischemia model.[4]
To further clarify the significance of rod formation, 
we undertook this study to compare rod formation 
in well‑established models of neuroprotection in 
experimental stroke. We anticipate that rod formation 
under the conditions of ischemic neuroprotection may 
provide insight into the significance of these rods. In this 
study, we chose therapeutic hypothermia (Hypo) and the 
70 kD inducible heat shock protein (Hsp70) as models of 
neuroprotection. We and others have previously shown 
that therapeutic cooling and Hsp70 overexpression 
or induction led to consistent reduction in lesion size 
and improvement in neurological deficits.[16,17] We also 
compared this in a model of Hsp70 deficiency, where 
ischemic brain injury led to worsened outcomes.[18] We 
predicted, based on past literature, that cofilin rods 
should increase with ischemic brain injury and decrease 
under neuroprotective conditions.
Materials and Methods
Animals
All experimental procedures were approved by the San 
Francisco Veterans Affairs Medical Center Institutional 
Animal Care and Use Committee, and were in accordance 
with the National Institutes of Health and Animal 
Research: Reporting in vivo Experiments guidelines.
For  the genetic  mouse models ,  male  Hsp70 
transgenic (Hsp70Tg) and Hsp70 knockout (Hsp70Ko) 
mice were produced from breeder mice originally 
generated by the Dillmann (University of California, 
San Diego)[19] and Pandita (Southwestern University) 
laboratories,[20] as described in our previous report.[18] 
Hemizygotic (Hsp70 Tg) and homozygotic (Hsp70 Ko) 
mice were compared with wild‑type (Wt) littermates. 
All other experiments were carried out on male C57/
BL6 mice.
Stroke model and hypothermia treatment
All surgical techniques were performed under aseptic 
conditions. Stroke surgeries were performed under 
inhalational anesthesia. Anesthesia was induced by 
inhalation of 3% isoflurane in medical air: O2 (80%:20%). 
Surgical planes of anesthesia were assessed by the 
absence of hindleg withdrawal in response to a pinch. 
A 1‑cm skin incision was created between the left margin 
of the orbit and the tragus, and the temporalis muscle 
was incised. A focal cerebral infarct was induced by 
permanent occlusion of the left distal middle cerebral 
artery (dMCAO) as previously described.[21,22] Briefly, a 
small craniotomy was made above the proximal segment 
of the middle cerebral artery (MCA), and the MCA was 
exposed after the dura was opened and retracted. The 
MCA was occluded by coagulation at the MCA segment 
just proximal to the olfactory branch. Rectal temperature 
was maintained between 36.5°C and 37.5°C during the 
procedures by using a thermometer connected to a 
heating pad. At the end of the surgery, the craniotomy 
and incision sites were closed, and the animals were 
allowed to recover. Mice were returned to their cages, 
were allowed free access to food and water, and were 
housed in a climate‑controlled environment (25°C). 
The mice were included in the study if they showed 
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neurological deficits as defined by a Bederson score of 
at least 3 (circling behavior) at 24 h post‑dMCAO.
For Hypo studies, Wt mice were randomly divided into a 
Hypo treatment group and a normothermic (nontreatment, 
control) group. In the Hypo group, cooling began at the 
time of dMCAO and maintained for 2 h with a rectal 
temperature of 31°C, followed by rewarming. This 
paradigm was chosen as it was previously shown to 
consistently lead to neuroprotection in our hands.[23,24] 
In the normothermic group, rectal temperature was 
maintained in the normal range (36.5°C–37.5°C) 
throughout the experiment.
Animals with no observable neurological deficits at the 
time of recovery from anesthesia were removed from the 
experiment. The animals were sacrificed at 4, 24, and 48 
h after ischemia for the following studies.
Neurobehavioral assessment
Neurological assessments using a modified Bederson’s 
score were performed using a neurological scoring system 
before surgery and 2 and 24 h afterward.[25,26] This score 
was modified for use in mice and applied as follows: 0, 
no observable neurological deficit; 1, unable to extend 
the contralateral forelimb; 2, flexion of the contralateral 
forelimb; 3, mild circling to the contralateral side; 4, severe 
circling; and 5, falling to the contralateral side.
Histology
At the end of the observational period, the mice were 
euthanized with an isoflurane overdose followed by brain 
removal. The mice were perfused transcardially with cold 
normal saline. Brains were sunk in 20% sucrose overnight 
and frozen at − 80°C. Frozen sections (40 µm thickness) 
were cryosectioned in the coronal plane. Sections were 
permeabilized with 95% methanol and 5% 0.01 M 
phosphate‑buffered saline for 15 minutes at ‑20˚C.[15]
Infarct volume assessment
To evaluate infarct volume, the brain sections were 
stained with cresyl violet, as previously described.[18,27] 
Coronal sections at the level of the third ventricle, 1.2 mm 
posterior to the bregma, were stained with cresyl violet. 
We identified areas of damage depending on microscopic 
evidence of cell death. The infarct areas were measured 
using an image analysis system (ImageJ, NIH, Bethesda, 
MD, USA) and calculated by subtracting the normal 
ipsilateral area from that of the contralateral hemisphere 
to correct for brain edema.[28]
Immunohistochemistry and image analysis
To assess the temporal change of cofilin rod formation 
after stroke, tissue sections were harvested 4 and 24 h after 
stroke and were stained by rabbit anti‑cofilin antibody 
(1:500, ACFL02, Cytoskeleton, Denver, CO, USA). After 
overnight (4°C) incubation in primary antibodies, the 
sections were reacted with secondary antibodies (Alexa 
Fluor 594 conjugated goat anti‑rabbit IgG (1:1000, Life 
Technologies, Carlsbad, CA, USA) at room temperature 
for 1 h. The stained sections were mounted on glass 
slides in 4’,6’‑diadino‑2‑phenylindole (DAPI)‑containing 
mounting medium (Vector Laboratories, Burlingame, 
CA, USA). Antibody to cofilin‑1 was used to identify 
the formation of cofilin‑actin rods, utilizing the fact that 
the aggregated cofilin‑1 in the rods generates a signal far 
greater than the background cofilin‑1 signal.[15]
All images were prepared for confocal microscopy under 
identical illumination and data capture conditions. 
Investigators photographing and analyzing the 
immunostains were blinded to the experimental conditions.
For the quantitative analysis, a coronal section 0.2 mm 
posterior to the bregma was used. For each section, 
quantitative analysis of cofilin‑actin rod expression was 
carried out in predefined regions: the “MCA border, the 
“ischemic core,” and the “ischemic borderzone.” This 
approach was used to permit comparisons at different 
time points, during which the anatomical location of 
borderzone evolves. As the MCA border is assumed to 
be the farthest margin occupied by an infarction due 
to MCAO, the MCA border may be considered the 
area where the ischemic region may be spared with a 
suitable neuroprotective treatment; the MCA border 
was anatomically defined as constant regions at 1.8 
and 3.6 mm lateral from the midline, within the cortex 
corresponding to the edge of the brain supplied by the 
MCA.[21,29] The “ischemic core” was defined as the center 
of the ischemic lesion, well within the boundaries of the 
infarct. The “ischemic borderzone” was defined as the 
region immediately adjacent to the ischemic lesion,[15] 
as visually delineated by NeuN and DAPI staining. 
These regions of interest (ROI) were defined as shown in 
Figures 1a and 3a. Brains were harvested 4 and 24 h after 
stroke. In each area, ROI (nonoverlapping high‑power 
fields; × 630) were selected and photographed for 
quantitative analysis. Analysis of cofilin rod expression 
was performed using ImageJ software (NIH, Bethesda, 
MD, USA). The immuno‑positive area was automatically 
measured with binary images processed by Image J 
software in the selected ROIs and expressed as percent 
of the area of ROI area, as reported previously.[15]
Statistical analysis
The animals were randomized to the different experimental 
groups, and all ratings and analyses were performed by 
investigators blinded to the experimental conditions. 
Sample size calculations were performed based on our 
prior studies.[22,27] All statistical analyses were performed 
using GraphPad Prism version 7.0 (GraphPad Software, 
San Diego, CA, USA). All data were presented as the 
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mean ± standard error. The differences between the two 
groups were compared using an unpaired t‑test, and 
multiple comparisons were performed using one‑way 
ANOVA followed by Bonferroni’s post hoc test where 
data were normally distributed. Nonparametric tests 
of Mann–Whitney or Wilcoxon rank‑sum were applied 
where data were not normally distributed. P < 0.05 was 
considered statistically significant.
Results
All animals survived the stroke surgeries. There were 
no mortalities and no exclusions.
Therapeutic hypothermia is neuroprotective 
against experimental stroke
Consistent with previously published reports, therapeutic 
Hypo provided neuroprotection against experimental 
stroke in mice.[23] Neurological deficits after dMCAO surgery 
were significantly better in the hypothermia‑treated mice 
(Hypo) compared to that of control mice (Wt) [Figure 2a]. At 
the time of recovery from anesthesia and Hypo treatment 
(2 h after dMCAO), no significant difference in neurological 
deficit was observed, whereas at the time of 24 h after 
dMCAO surgery, statistically significantly (P < 0.05) better 
score of modified Bederson’s scoring system was observed 
in Hypo‑treated mice (1.0 ± 0.0), compared to that of control 
mice (2.5 ± 0.39).
In line with neurological assessments, Hypo decreased 
infarct volume after dMCAO [Figure 2b]. Hypothermic 
mice (Hypo; 8.6% ± 2.7%) showed statistically 
significantly (P < 0.01) smaller infarct volumes compared 
to that of control mice that remained normothermic (Wt; 
22.6% ± 0.7%) from cresyl violet stains 48 h after dMCAO. 
These findings are in line with prior observations that 
Hypo treatment can provide a significant neuroprotective 
effect in experimental stroke.[17,23,30]
Hypothermia‑reduced cofilin‑actin rod formation
Cofilin‑actin rod formation was assessed 4 and 24 h 
after dMCAO surgery in the MCA border and ischemic 
core (defined in the methods section). A representative 
image from the area of the MCA border [Figure 1b] shows 
that cofilin‑actin rods are visible 4 h after dMCAO in the 
ischemic core and, to a lesser extent, the MCA borderzone. 
By 24 h, rod formation increased in the MCA borderzone 
among normothermic mice, whereas fewer rods were seen 
within the ischemic core. In contrast, rod formation reduced 
in mice treated with Hypo at both 4 and 24 h. Figure 1c 
shows quantitative results from the “ischemic core” and 
“penumbra.” In the “ischemic core,” the % area occupied 
by cofilin‑actin rods statistically significantly (P < 0.05) 
decreased in Hypo mice at 24 h after stroke, compared to 
that of Wt. At the MCA border, Hypo mice had statistically 
significantly less rod formation compared to Wt mice, at 
both 4 (P < 0.05) and 24 h (P < 0.01) after stroke.
Figure 1: Cofilin‑actin rod formation was reduced by therapeutic hypothermia. (a) Schematic showing where regions of interests were sampled as they represented 
the ischemic core (3.6 mm from Bregma, blue squares) and the brain margins supplied by the middle cerebral artery (MCA border 1.8 mm from Bregma, red squares). 
(b) Representative images of cofilin (red) and DAPI (blue) staining taken from the MCA border at 4 and 24 h postmiddle cerebral artery occlusion among normothermic and 
hypothermic animals. Fewer rods were observed in the hypothermia brain. (c) Quantification of the brain regions shows the percentage area occupied by cofilin‑actin rods 
within the ischemic core and middle cerebral artery (MCA) border at 4 and 24 h. Within the core, rods increased in both groups at 4 h and markedly reduced at 24 h, with 
significant reduction in the hypothermia group at 24 h. Within the MCA border, rods were more marked at 24 h compared to 4 h, but at both time points, rods were reduced in 
the hypothermia group (*P < 0.05, ***P < 0.01)
cba
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The reduction of cofilin rod formation by therapeutic 
Hypo was not simply due to reduced infarct volume, 
as it was also reduced in the ischemic borderzone 
regions of the smaller infarcts seen in brains of the Hypo 
mice [Figure 3]. When the ischemic borderzone area of 
the lesions was assessed, ROIs were set as shown in 
Figure 3a. The ischemic borderzone region varied from 
animal to animal, depending on where the edge of the 
NeuN staining occurred. Representative images obtained 
from borderzone regions [Figure 3b] show that in the Wt 
group, cofilin‑actin rod formation increased at both 4 
and 24 h after stroke, but markedly suppressed in Hypo 
mice. Quantitative analysis revealed that cofilin‑actin rod 
formation statistically significantly reduced in mice with 
Hypo treatment (Hypo) compared to control mice (Wt), at 
both 4 (P < 0.05) and 24 h (P < 0.01) after stroke [Figure 3c]. 
These results suggest that under the conditions of 
therapeutic Hypo, cofilin‑actin rod formation is reduced.
Hsp70 and neuroprotection after experimental stroke
We then turned to a second model of neuroprotection and 
studied Tg mice that overexpress Hsp70 (Hsp70 Tg) and 
compared them to mice which lack Hsp70 (Hsp70Ko). 
We had previously shown that Hsp70 Tg mice have 
smaller infarcts and better neurological scores compared 
to Wt,[26] whereas Hsp70Ko mice have the opposite.[18] 
Figure 3: Cofilin‑actin rod formation was reduced by hypothermia in the ischemic borderzone. (a) Schematic showing where regions of interest were sampled from the 
ischemic borderzone. In contrast to the middle cerebral artery border (MCA border), this area was defined as the region adjacent to the infarct and where DAPI and NeuN 
staining were present (red squares). (b) Representative images taken from the ischemic borderzone regions of normothermic (Wt, wild type) and hypothermic (Hypo) brains 
showing cofilin rods (red). Nuclei are shown by DAPI staining (blue). (c) Quantification of cofilin staining from the borderzone region. Cofilin staining was higher at 24 h 
compared to 4 h, but the extent of staining was reduced in hypothermia brains at both time points (*P < 0.05, **P < 0.01)
cba
Figure 2: Hypothermia protects against experimental stroke. (a) Bederson scores, to estimate neurological deficits, were improved under the conditions of therapeutic 
hypothermia (Hypo) 24 h post middle cerebral artery occlusion compared to animals exposed to middle cerebral artery occlusion under normothermic conditions (Wt, wild 
type). (b) Infarct volumes at 24 h were also smaller among hypothermia animals. (*P < 0.05, **P < 0.01)
ba
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Consistent with our previously published reports,[18,26] 
Hsp70 overexpression led to improved neurological 
outcomes, whereas Hsp70 deficiency led to worsened 
outcomes compared to Wt mice. Neurological deficits 
assessed by the modified Bederson’s scoring system 
improved among Hsp70 Tg mice (1.3 ± 0.3) and worsened 
in Hsp70Ko mice (3.0 ± 0.2), compared to that of Wt 
mice (2.5 ± 0.4), at 24 h after dMCAO surgery [Figure 4a]. 
Similarly, infarct volumes [Figure 4b] measured from 
cresyl violet‑stained brain sections were significantly 
smaller in the Hsp70 Tg mice (7.2% ± 2.2%) and 
significantly larger in the Hsp70Ko mice (28.7% ± 2.2%), 
compared to that of Wt mice (22.5% ± 0.7%).
Hsp70 overexpression decreases and Hsp70 
deficiency increases cofilin‑actin rod expression
Similar to assessments carried out in the Hypo 
studies, formation of cofilin‑actin rods was measured 
in the MCA border, ischemic core, and ischemic 
borderzone at 4 and 24 h after stroke. Representative 
images obtained from the MCA border are shown 
in Figure 5a. Compared to Wt mice, Hsp70Ko mice 
showed increased expression of cofilin‑actin rod at 
both 4 and 24 h after stroke. In contrast, Hsp70Tg mice 
showed decreased expression of cofilin‑actin rods at 
both 4 and 24 h after stroke. Results of the quantitative 
analysis in the ischemic core and MCA border are 
Figure 5: Cofilin‑actin rod formation was decreased by Hsp70 overexpression and increased by Hsp70 deficiency. (a) Representative images from the middle cerebral artery 
border of wild type (Wt), Hsp70 knockout (Ko), and Hsp70 transgenic (Tg) brains show that cofilin staining (red) is the highest among the Hsp70 knockout brain compared to 
wild type and Hsp70 transgenic. (b) Quantification of cofilin staining shows that Hsp70‑deficient (knockout) brains had the most cofilin staining, whereas the least was seen in 
brains of mice where Hsp70 was overexpressed (transgenic). Wild type brains had an intermediate amount of cofilin staining (*P < 0.05, **P < 0.01, ***P < 0.001)
ba
Figure 4: Hsp70 overexpression improves outcome from experimental stroke, whereas Hsp70 deficiency worsens it. (a) Neurological deficits as estimated by the Bederson 
score were similar 2 h postmiddle cerebral artery occlusion among wild type (Wt), Hsp70‑deficient (Ko, knockout) and Hsp70‑overexpressing (Tg, transgenic) mice, but by 
24 h, deficits were the most severe among the knockout and least severe among the transgenic groups. (b) Lesion volumes at 24 h increased in the knockout brains and 
decreased in the transgenic brains compared to wild type. *P < 0.05, **P < 0.01, ***P < 0.001
ba
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shown in Figure 5b. In the ischemic core, Hsp70Tg 
mice showed decreased cofilin‑actin rod formation. In 
the area of the MCA borderzone, quantitative analysis 
revealed that cofilin‑actin rod expression at both 4 and 
24 h after stroke significantly increased in Hsp70Ko 
mice (4 h, P < 0.001; 24 h, P < 0.05) and significantly 
decreased in Hsp70Tg mice (4 h, P < 0.001; 24 h, 
P < 0.01), compared to Wt mice.
Similar to observations from the Hypo studies, cofilin 
rod formation was not simply altered because of the 
differences in infarct size. Representative images 
obtained from MCA borderzone regions are shown 
in Figure 6a. Hsp70Ko mice have increased cofilin‑
actin rod formation, whereas Hsp70Tg mice have 
fewer cofilin‑actin rods at both 4 and 24 h after stroke, 
compared to that of Wt mice. Quantitative analysis 
revealed similar patterns comparing Hsp70Tg and Wt 
groups at both 4 (P < 0.05) and 24 h (P < 0.001) after 
stroke. In contrast, Hsp70Ko mice showed more cofilin‑
actin rods compared to Wt mice, at 24 h (P < 0.05) after 
stroke [Figure 6b].
Discussion
In line with prior reports of neuroprotection by 
therapeutic Hypo and Hsp70 overexpression, our 
studies also showed that these interventions led to 
improved neurological outcome, whereas mice deficient 
in Hsp70 (Hsp70Ko) had worsened outcomes. In 
parallel, cofilin‑actin rod formation decreased under 
the conditions of improved outcomes and increased 
when neurological outcomes are worse. Together, these 
observations are consistent with the idea that cofilin‑actin 
rod formation may contribute to ischemic brain injury, 
particularly injury to neuronal processes.
As both experiments led to changes in infarct volume 
due to the interventions themselves, this imposed a 
technical challenge for quantifying peri‑infarct rod 
formation. Our first approach evaluated rod formation in 
all brains at the same anatomical site that corresponded 
to a penumbral region at the very edge of the territory 
supplied by the MCA (MCA border), but also where we 
observed rod formation in the normothermic Wt mice. 
However, that approach could be biased because that 
the same anatomical location in the Hypo and Hsp70 Tg 
mice would have been further from the infarct margins 
because their infarcts are generally smaller. Conversely, 
the anatomic location among Hsp70‑deficient mice 
would be closer to the ischemic core due to the generally 
larger infarcts observed in these mice. For these reasons, 
we also assessed rod formation in regions defined by the 
infarct margin (ischemic borderzone), independent of the 
infarct size. As we show, using either criteria, both Hypo 
and Hsp70 overexpression suppressed rod formation at 
both 4 and 24 h, in addition to reducing infarct volume, 
whereas Hsp70 deficiency did the opposite.
Hypothermia has previously been shown to reduce 
oxidative stress in ischemic brain,[17] and oxidative 
stress has also been shown to drive cofilin‑actin rod 
formation. Cofilin rod formation results from actin 
binding and requires dephosphorylation of cofilin‑1. Rod 
formation also requires the formation of intermolecular 
disulphide bonds between cofilin‑1 molecules. Both 
of these steps are promoted by oxidative stress in the 
Figure 6: Cofilin‑actin rod formation within the ischemic borderzone was decreased by Hsp70 overexpression and increased by Hsp70 deficiency. (a) Representative 
images from the ischemic borderzone regions of wild type (Wt), Hsp70 knockout (Ko), and Hsp70 transgenic (Tg) brains show that cofilin staining (red) is the highest among 
the Hsp70 knockout brain and lowest in the Hsp70 transgenic brain, with intermediate staining in the wild‑type brain. (b) Quantification of cofilin staining shows that Hsp70 
deficient (knockout) brains had the most cofilin staining, while the least was seen in Hsp70 overexpression (transgenic). Wild‑type brains had an intermediate amount of 
cofilin staining (#P < 0.05 vs. wild type, ###P < 0.001 vs. wild type; **P < 0.01, ***P < 0.001)
ba
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following manner. First, SL phosphatase (SSH‑1 L) 
dephosphorylates cofilin‑1 and is itself activated by 
release from the scaffolding protein 14‑3‑3ζ under 
oxidant stress conditions. Second, the oxidation of 
cysteines 39 and 147 of cofilin‑1 to sulfenic or sulfinic 
acids facilitates subsequent formation of intermolecular 
disulfide bonds between cofilin‑1 molecules that stabilize 
rod formation.[1,2] These mechanisms thus provide a 
potential pathway by which Hypo suppresses rod 
formation, but given the pleiotropic effects of Hypo 
on cell physiology, other mechanisms are also likely 
possible.
How Hsp70 overexpression might suppress rod 
formation is not immediately apparent, as to our 
knowledge, no direct interactions between Hsp70 
and cofilin‑1 or actin have been described. However, 
Hsp70 has previously been shown to protect the 
hypothalamus against oxidative stress in models of 
heat stroke[31] and in cultured hippocampal neurons. 
Hsp70 has also been shown to attenuate inflammation 
after brain ischemia,[26,32] which, in turn, would also lead 
to reductions in oxidative stress. Hsp70 may affect rod 
formation simply by its chaperone functions, where 
it has been shown to prevent protein aggregation in 
several models of neurological disease.[33,34] Whether 
either property is a significant factor mediating the 
neuroprotection observed with Hypo remains to be 
established.
Conclusions
The observations presented here establish correlations 
between Hypo and reduced rod formation and 
between Hsp70 and reduced rod formation after brain 
ischemia, but they do not prove that reduced rod 
formation is a major factor mediating either beneficial 
effect. However, our observations that rod formation 
is reduced under the conditions of neuroprotection 
indicate that their presence is likely to be more 
harmful than beneficial in brain ischemia. Further, 
mechanisms of injury to neuronal processes (dendrites 
and axons) are poorly understood, and cofilin rod 
formation is becoming increasingly recognized as both 
a marker and participant in their pathology. Ongoing 
studies using genetic and pharmacological means 
of suppressing cofilin rod formation may be able to 
resolve this contribution of suppressed rod formation 
to preservation of neuronal processes by Hypo and 
Hsp70.
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